AI Risk-Stratification: The VBC Investment Imperative

The healthcare industry’s financial model is being turned on its head, moving away from the transactional fee-for-service grind toward a system that pays for value and outcomes. This isn’t some abstract academic shift. It’s a macro trend driven hard by federal policy, especially the Medicare Shared Savings Program (MSSP). It’s forcing providers to get serious about proactively managing their patient populations. For anyone investing in value-based care, understanding how this government push creates a huge appetite for AI risk-stratification tools is the key to finding digital health investments that will actually last.

The Policy Imperative: CMS and the Rise of Risk-Bearing Contracts

The whole value-based care (VBC) movement really starts with the Centers for Medicare and Medicaid Services (CMS). They’ve been the primary engine pushing for models that reward quality, not just quantity of care. The MSSP is the big one, creating Accountable Care Organizations (ACOs) and telling them to take on real financial risk for their patients. If they deliver high-quality care and keep costs below a benchmark, they get a bonus. This completely changes the math for a hospital or a clinic. You can’t just bill for every visit and procedure anymore. Now you’re on the hook for the total cost of care and the actual health of the people you’re treating. This creates an immediate, urgent need for a crystal ball. To survive in these risk-bearing contracts, ACOs have to figure out which patients are most likely to have a bad outcome, end up in the hospital, or rack up huge bills before it happens. That’s the only way you can get ahead of it with targeted interventions, better care coordination, or chronic disease management, all the stuff that improves patient health and lets you hit those shared savings targets. Trying to manage thousands of patients under a VBC contract without good risk stratification is just guessing, and it’s a great way to lose a lot of money. CMS keeps doubling down, pushing to tie more and more Medicare payments to these value models, which makes a solid risk-stratification setup a non-negotiable part of the playbook CMS Medicare Shared Savings Program regulations. CMS is continuing to propose major reforms to physician payment and VBC programs to expand accountable care, modernize how doctors get paid, and cut down on paperwork, all to shift the focus from treating sickness to preventing it. For the 2026 performance year alone, CMS greenlit 134 applications for the Shared Savings Program which included 72 brand-new ACOs.

AI as the Essential Infrastructure for MSSP Success

The amount and complexity of healthcare data today means you can’t do this kind of risk analysis with a spreadsheet and a couple of analysts. It’s just not possible. This is where AI tools become the only practical option. Predictive algorithms can tear through gigantic datasets, claims, electronic health records (EHRs), social determinants of health info, even real-time data from wearables, to spot patterns and predict risk for each individual patient. These tools go way beyond just looking at a patient’s age and zip code. They factor in thousands of subtle clinical markers and behavioral data points to generate risk scores that are far more accurate and, more importantly, actionable. For an ACO in the MSSP, being able to pinpoint its highest-risk members means it can aim its limited resources (like care managers or social workers) at the people who will benefit the most. Maybe you deploy a care manager to a patient with three chronic conditions, or you push for preventive screenings for someone whose data suggests they’re on the verge of developing diabetes, or you set up a customized medication adherence program. You can directly measure the results of these actions in lower hospital readmissions, fewer ER visits, and better control of chronic diseases, all of which are the exact metrics that determine your MSSP performance and whether you get a shared savings check. By Performance Year 2023, two-thirds of ACOs were already reporting that they could identify and target beneficiaries with predictive risk stratification. That adoption rate is climbing fast because organizations see the direct line between these algorithms and their financial performance in VBC models. CMS is also looking into how AI is changing primary care and thinking about how Medicare should pay for these AI-driven services. Predictive algorithm adoption rates in ACOs.

Leaders in AI for Value-Based Care Enablement

A few companies have already established themselves as the ones to watch in using AI for risk stratification, proving there’s a real, commercially-viable market here. They show how AI is being put to work to solve the fundamental problems of value-based care. Oak Street Health, which CVS Health bought in 2023, runs primary care clinics for Medicare patients. Their entire business model is built on sophisticated risk stratification. By catching high-risk patients early, Oak Street can wrap them in intensive, proactive care that includes longer appointments, social support, and tight care coordination. That whole approach, which depends on their internal analytics, lets them manage very sick, complex patients and produce better health outcomes and big savings in their capitated contracts. Their success is a direct validation of the investment thesis for AI-powered population health. (Though it’s worth noting, in September 2024, Oak Street Health paid $60 million to resolve federal allegations of kickbacks to insurance agents). Aledade has a different, but just as effective, model. It acts as a tech and services partner for independent primary care practices, grouping them into physician-led ACOs. Aledade gives these small practices the technology and data analytics they need to have a fighting chance in value-based care. The core of what they offer are AI tools that help doctors spot at-risk patients, close gaps in care, and make smarter referrals. By pooling data from thousands of small practices, Aledade’s AI gets smarter and more accurate, creating a powerful data advantage that helps these practices make the leap from fee-for-service to risk. As of February 2025, Aledade was supporting over 2,400 primary care providers covering nearly 3 million patients. In July 2026, they brought in a new CTO and a Chief Scientist specifically to push their AI capabilities even further. Pearl Health provides software that helps primary care doctors transition to value-based models. Their platform uses AI to give providers insights they can actually use, like patient risk scores, alerts about care gaps, and clear opportunities to save money. Pearl’s tech makes it possible for independent doctors to participate in programs like the MSSP because it gives them the tools to understand and manage their patient panel like a big health system would. Their rapid growth is a clear signal of the demand for accessible AI solutions that take some of the risk out of moving to VBC. In July 2026, Pearl Health raised another $110 million to build out its AI platform after hitting profitability in 2025. The company now manages about $3.6 billion in medical spend and supports over 10,000 providers across 40 states. What’s the pattern here? The companies with strong clinical results and solid payer contracts, often built on advanced AI, are the ones attracting durable funding. Their solutions directly answer the financial and operational questions of a healthcare system that’s being rewired to pay for value.

Investor Takeaway: Connecting Policy to Profitability

For investors looking at healthcare policy and value-based care, the message is simple. The federal government’s relentless push into VBC, with MSSP leading the charge, is creating a massive and sustainable demand for AI-powered risk-stratification software. Companies that use AI to help providers manage populations, cut costs, and improve outcomes in risk-based contracts are selling essential infrastructure for the future of medicine. When you’re looking at an investment in this space, you have to dig into the company’s ability to show a clear return on investment (ROI) for providers. Can they prove they’re improving MSSP savings rates? Do they have data showing reductions in avoidable hospital stays? Can they point to better patient health metrics? In 2024, the Medicare Shared Savings Program generated a record $6.5 billion in gross savings, with $2.48 billion in net savings to taxpayers. The program’s overall savings rate was 4.7%. Since it started in 2012, MSSP has saved Medicare $35 billion gross and $13.6 billion net. As of January 2026, an estimated 14.3 million Medicare beneficiaries get their care from an ACO. You also have to look at the strength of a company’s data moat, its commitment to Good Machine Learning Practice (GMLP), and whether it can handle the regulatory maze of healthcare (like HIPAA compliance and SOC 2 certification). Those are the signs of a company built for the long haul with real exit potential Medicare Shared Savings Program financial results. The economic forces pushing value-based care aren’t going away. This is a deep restructuring of how healthcare gets paid for, and that makes AI-powered risk stratification a foundational investment thesis for a long time to come.

Methodology and Source Note

This analysis connects the dots between federal VBC policy and the demand for AI software by looking at CMS timelines and ACO performance data. All the information here comes from publicly available data from CMS on the Medicare Shared Savings Program, plus the stated business models of the companies mentioned. You should always verify specific numbers like MSSP savings rates and AI adoption rates against the latest official CMS publications and other industry reports. The goal here is to provide a factual resource for investors that lays out the policy drivers behind VBC software and the central role AI plays in this changing field.